Literature DB >> 12943808

Sphingosine-1-phosphate stimulates smooth muscle cell migration through galpha(i)- and pi3-kinase-dependent p38(MAPK) activation.

Allison J Fegley1, William J Tanski, Elisa Roztocil, Mark G Davies.   

Abstract

BACKGROUND: Sphingosine-1-phosphate (S-1-P) is an extracellular mediator released in response to vessel injury. S-1-P binds to G-protein-coupled receptors, which can be Galpha(i)-, Galpha(q)-, or G(12/13)-linked. This study examines the role of p38 mitogen-activated protein kinase (p38(MAPK)) in vascular smooth muscle cell migration after stimulation with S-1-P, and pathways leading to p38(MAPK) activation. S-1-P has previously been shown to stimulate migration of vascular smooth muscle cells (VSMCs) in vitro through ERK1/2 and G(i). We hypothesized that S-1-P-induced VSMC migration is also dependent on p38(MAPK) activation through a G(i)-coupled extracellular receptor and phosphoinositide 3-kinase (PI3-K).
METHODS: VSMCs were cultured in vitro. A linear wound assay was performed in the presence of S-1-P and inhibitors of p38(MAPK) (SB203580) or epidermal growth factor (EGF) receptor kinase (AG1478). Chemotaxis stimulated by S-1-P was also assayed in a modified Boyden chamber with and without SB203580 pretreatment. Western blotting was performed to examine p38(MAPK) activation in response to S-1-P with and without SB203580, AG1478, or inhibitors of G(i) (pertussis toxin), PI3-K (Wortmannin and LY294002), or MEK1 (PD98059). Western blotting and immunoprecipitation for targets of p38(MAPK) (MAPKAP kinase-2) and PI3-K (Akt) were also performed.S-1-P stimulated migration of VSMCs in both wound and Boyden transwell assays. This migration was inhibited by SB203580 to the level of control, whereas AG478 had no effect.
RESULTS: S-1-P stimulated activation of p38(MAPK) that peaked at 10 min, as well as activation of MAPKAP kinase-2. Activation of p38(MAPK) was significantly inhibited by SB203580, pertussis toxin, Wortmannin, and LY294002, but not by PD98059 or AG1478; MAPKAP kinase-2 activation was inhibited by SB203580. Akt was activated by S-1-P at 3 to 5 min; this response was inhibited by Wortmannin and LY294002, but not by SB203580 or pertussis toxin.
CONCLUSIONS: S-1-P induced VSMC migration through a G(i)-linked and a PI3-K coupled, p38(MAPK)- dependent process. PI3-K appears to function upstream of p38(MAPK), but was not G(i)-dependent. S-1-P-stimulated activation of p38(MAPK) does not signal via transactivation of the EGF receptor. Understanding signal transduction will allow targeted molecular interventions to treat the response of a vessel to injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943808     DOI: 10.1016/s0022-4804(03)00120-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

1.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

2.  SRC regulates sphingosine-1-phosphate mediated smooth muscle cell migration.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2011-08-10       Impact factor: 2.192

3.  Role of S-1-P receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-03-11       Impact factor: 2.192

4.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

5.  Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Galpha12/13 protein-mediated phospholipase C activation.

Authors:  Eliza Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Vasc Surg       Date:  2007-12       Impact factor: 4.268

6.  Mechanisms of sphingosine-1-phosphate-induced akt-dependent smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  Surgery       Date:  2008-09-11       Impact factor: 3.982

Review 7.  Physiology and pathophysiology of canonical transient receptor potential channels.

Authors:  Joel Abramowitz; Lutz Birnbaumer
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

8.  Increased aerobic glycolysis is important for the motility of activated VSMC and inhibited by indirubin-3'-monoxime.

Authors:  Elke H Heiss; Daniel Schachner; Maddalena Donati; Christoph S Grojer; Verena M Dirsch
Journal:  Vascul Pharmacol       Date:  2016-05-14       Impact factor: 5.773

Review 9.  Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation.

Authors:  Shailaja Mahajan-Thakur; Andreas Böhm; Gabriele Jedlitschky; Karsten Schrör; Bernhard H Rauch
Journal:  Mediators Inflamm       Date:  2015-10-29       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.